Like Countable?

Install the App
TRY NOW

house Bill H.R. 4841

Co-Prescribing Saves Lives Act of 2016

Bill Details

Official information provided by the Congressional Research Service. Learn more or make a suggestion.
The Congressional Research Service writes summaries for most legislation. These summaries are listed here. Countable will update some legislation with a revised summary, title or other key elements.

Suggest an update to this bill using our form.

Title

Co-Prescribing Saves Lives Act of 2016

Official Title

To establish programs for health care provider training in Federal health care and medical facilities, to establish Federal co-prescribing guidelines, to establish a grant program with respect to naloxone, and for other purposes.

Summary

Co-Prescribing Saves Lives Act of 2016 This bill requires the Department of Health and Human Services (HHS), the Department of Veterans Affairs (VA), and the Department of Defense (DOD) to: (1) establish training guidelines for federal health care facilities and federally qualified health centers; and (2) train certain health care providers at federal health care facilities on best practices for prescribing pain medications, principles of pain management, the misuse potential of controlled substances, identification of potential substance use disorders and referral to further evaluation and treatment, and disposal of controlled substances. HHS, the VA, and DOD must establish, for certain health care facilities, guidelines for the prescription of naloxone to individuals at an elevated risk of overdose. (Naloxone is a prescription drug used to rapidly reverse an overdose of opioids, which are drugs with effects similar to opium, such as heroin and certain pain medications.) HHS must award grants to state departments of health for the development and application of guidelines for the prescription of opioid overdose reversal drugs and to increase access to naloxone. Grants may be used to: establish a program for purchasing, prescribing, and distributing opioid overdose reversal drugs; expand innovative models of naloxone distribution; train and provide resources to health care providers and pharmacists on prescribing opioid overdose reversal drugs; offset individuals' cost-sharing for opioid overdose reversal drugs; conduct community outreach to raise awareness of the availability of opioid overdose reversal drugs; and establish protocols to connect patients who have experienced a drug overdose with treatment.

bill Progress


  • Not enacted
    The President has not signed this bill
  • The senate has not voted
  • The house has not voted
      house Committees
      Indigenous Peoples of the United States
      Committee on Armed Services
      Military Personnel
      Committee on Energy and Commerce
      Health
      Committee on Natural Resources
      Committee on Veterans' Affairs
    IntroducedMarch 23rd, 2016

    There are currently no opinions on this bill, be the first to add one!